12
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Chronic Fatigue Syndrome

Evaluation of a 30-Criteria-Score and Correlation with Immune Activation

&
Pages 35-47 | Published online: 04 Dec 2011

References

  • Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S. Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: a working case definition. Ann Int Med. 1988;108 (3)387–389.
  • Fukuda K, Straus SE, Hickie I. Sharpe MC, Dobbins JO, Komaroff A. In-ternational CFS Study Group. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study. Ann Int Med. 1994;121 (12):953–959.
  • Patarca R, Fletcher MA, Klimas NO. Immunological correlates of chronic fatigue syndrome. In: Goodnick PJ, Klimas NO, eds.: Chronic Fatigue and Re-lated Immune Deficiency Syndromes. Washington—London: American Psychiat-ric Press, 1993:1–21.
  • Hilgers A, Frank J. Chronic Fatigue lmmundysfunction Syndrome bei 103 Patienten: Diagnostik, Befunde und Therapie. Z Klin Med. 1992;47 (4):152–164.
  • Hilgers A, Frank J. Chronic Fatigue Syndrome: Immundysfunktion, Erreg-er- und Schadstoffbeteiligung sowie neurologische und kardiale Verandeningen. WMW. 1994;144 (16):399–406.
  • Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991;338:707–712.
  • Ho-Yen DO, Billington RW, Urquhart J. Natural killer cells and the post viral fatigue syndrome, Scand J Infect Dis. 1991;23:711–716.
  • Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormal-ities in chronic fatigue syndrome. J Clin Microbiol. 1990;28 (6):1403–1410.
  • Patarca R, Lugtendorf S, Antoni M, Klimas NO, Fletcher MA. Dysregu-iated expression of tumor necrosis factor in the chronic fatigue immune dysfunc-tion syndrome: Interrelations with cellular sources and patterns of soluble im-mune mediator expression. Clin lnfec Dis. 1994;18:S1147–S1153.
  • Patarca R, Klimas NG, Garcia MN, Walters MJ, Dombroski D, Pons H, Fletcher MA. Dysregulated expression of soluble immune receptors in a subset of patients with chronic fatigue syndrome: cross-sectional categorization of patients by immune status. J Chronic Fatigue Syndrome. 1995;1 (0:81–96.
  • Patarca R, Klimas NG, Sandler D, Garcia MN, Fletcher MA. Interindividu-al immune status variation patterns in patients with chronic fatigue syndrome: association with the tumor necrosis factor system and gender. J Chronic Fatigue Syndrome, 1995; 2 (1):13–19.
  • Buchwald D, Komaroff AL. Review of Laboratory Findings for Patients with Chronic Fatigue Syndrome. Rev Infect Dis. 1991;13 (supp11):S12–S18.
  • Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein .1, Brus I, Blaese M. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Int Med. 1985;102: 7–16.
  • Vento S, Guella L, Mirandola F, CaineIli F, Di Perri G, Solbiati M, Ferraro T, Concia E. Epstein-Barr virus as a trigger for autoimmune hepatits in suscepti-ble individuals. Lancet. 1995;346:608–609.
  • Straus SE. Studies of herpesvirus infection in chronic fatigue syndrome. In: Chronic fatigue syndrome. Wiley, Chichester (Ciba Foundation Symposium 173), 1993:132–145.
  • Pollack Ri, Komaroff AL, Telford SR, Gleit M, Fagiolo L, Burnet LR, Spielman A. Borrelia burgdorferi infection is rarely found in patients with Chron-ic Fatigue Syndrome. Clin Infect Dis 1995;20 (2):467–486.
  • Lyme disease: the American divide. Conference report by D. Wright. Lan-cet 1994; 52.
  • Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol. 1995;74 (1):10–22.
  • Buchwald D, Garrity D. Comparison of Patients with Chronic Fatigue Syn-drome, Fibromyalgia and Multiple Chemical Hypersensitivities. Arch Intern Med. 1994;154 (9):2049–2053.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.